Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster Display session 1

3414 - DNA methylation profiles of angiosarcoma subtypes.


28 Sep 2019


Poster Display session 1


Tumour Site



Marije Weidema


Annals of Oncology (2019) 30 (suppl_5): v683-v709. 10.1093/annonc/mdz283


M.E. Weidema1, E. de Jong2, C. Koelsche3, I.M.E. Desar1, M.H.S. Hillebrandt-Roeffen1, W.T. van der Graaf4, Y.M.H. Versleijen-Jonkers1, A. Von Deimling5, U.E. Flucke6

Author affiliations

  • 1 Medical Oncology, Radboud University Medical Center, 6525 GA - Nijmegen/NL
  • 2 Research, Princess Máxima Center for Pediatric Oncology, Utrecht/NL
  • 3 General Pathology, Institute of Pathology, Heidelberg/DE
  • 4 Medical Oncology, Netherlands Cancer Institue - Antoni van Leeuwenhoek Hospital, Amsterdam/NL
  • 5 Neuropathology, University of Heidelberg, Heidelberg/DE
  • 6 Pathology, Radboud University Medical Center, Nijmegen/NL


Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract 3414


Angiosarcoma (AS) is a rare malignancy with a heterogeneous clinical presentation and genetic background. Different clinical AS subtypes can be envisaged, including: visceral, deep-seated soft tissue (ST), radiation induced (RT) and UV associated (UV) origin. To better understand their distinct biology and clinical outcome we investigated DNA methylation profiles, chromosomal stability and survival of these four subtypes.


After ethical approval, FFPE samples of AS from visceral, ST, RT and UV origin were collected from a nationwide search by the Dutch nationwide network and registry of histo- and cytopathology. DNA was extracted for methylation profiling with the Illumina Infinium MethylationEPIC array (German Cancer Research Center, Heidelberg, Germany). Quality control and unsupervised hierarchical clustering based on the 1% most varying methylation probes took place at Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands. Copy number profiles were generated for chromosomal stability assessment. Anonymized clinical data were obtained from the Netherlands Cancer Registry.


DNA methylation profiling and unsupervised hierarchical clustering of 36 AS samples (6 visceral, 5 ST, 14 RT, 11 UV), revealed two main clusters (A and B) and four subclusters (Table). The different clusters corresponded with clinical origin, showing enrichment of UV cases in cluster A1 and RT cases in cluster A2. Cluster A showed significantly more chromosomal aberrations and better median overall survival compared to cluster B (22.2 vs 5.5 months, p = 0.046).Table:

1711P Cluster characteristics

Subtype7 UV10 RT, 1 ST4 ST, 3 Visceral4 RT, 4 UV, 3 Visceral
Median survival (months, range)22 (2-106)23 (1-281)4 (2-55)7 (0-40)


In this novel DNA methylation profiling study, we demonstrated for the first time four different AS clusters. These clusters strongly correlated with clinical origin, chromosomal stability and overall survival. Further research is warranted in a larger patient cohort to better define the clinical significance of the different clusters.

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

The authors.


HDKT (Honderdduizend Keer een Tientje).


I.M.E. Desar: Research grant / Funding (institution): Novartis. W.T. van der Graaf: Research grant / Funding (institution): Novartis; Research grant / Funding (institution): Bayer. All other authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.